Genetic instability caused by mutations in the p53 gene is generally thought to be due to a loss of the DNA damage response that controls checkpoint functions and apoptosis. Cells with mutant p53 exhibit high levels of homologous recombination (HR). This could be an indirect consequence of the loss of DNA damage response or p53 could have a direct role in HR. Here, we report that p53À/À mouse embryonic fibroblasts (MEFs) exhibit higher levels of the RAD51 protein and increased level of spontaneous RAD51 foci Agents that stall replication forks, for example, hydroxyurea (HU), potently induce HR repair and RAD51 foci. To test if the increase in RAD51 foci in p53À/À MEFs was due to an increased level of damage during replication, we measured the formation of DNA double-strand breaks (DSBs) in p53 þ / þ and p53À/À MEFs following treatments with HU. We found that HU induced DSBs only in p53À/À MEFs, indicating that p53 is involved in a pathway to protect stalled replication forks from being collapsed into a substrate for HR. Also, p53 is upregulated in response to agents that inhibit DNA replication, which supports our hypothesis. Finally, we observed that the DSBs produced in p53À/À MEFs did not result in a permanent arrest of replication and that they were repaired. Altogether, we suggest that the effect of p53 on HR and RAD51 levels and foci can be explained by the idea that p53 suppresses formation of recombinogenic lesions.
Introduction
p53 is activated in response to a wide variety of DNA damage. Loss of p53 function causes an aberrant DNA damage response that may result in mutations and genetic instability. However, genetic instability in p53-deficient cells is also found in the absence of external damage (Schwartz and Rotter, 1998) . This is likely to be the consequence of endogenous DNA damage triggering p53. A stalled replication fork is a endogenous DNA damage (Cox, 2001) and is known to trigger p53 (Taylor et al., 1999; Gottifredi et al., 2001) . Thus, the genetic instability in untreated p53À/À cells may be the result following aberrant repair of a naturally occurring DNA damage that may arise during DNA replication.
Faithful DNA replication is maintained in the cell by homologous recombination (HR). Cells deficient in RAD51 (the mammalian RecA homologue) die from DSBs accumulated during the first round of replication in the absence of external DNA damage (Sonoda et al., 1998) . This is related to the role of RAD51 in HR repair of DNA damage at replication forks (Lundin et al., 2003) . p53 interacts and colocalizes with RAD51 at stalled replication forks (Sturzbecher et al., 1996; Buchhop et al., 1997; Susse et al., 2000; Sengupta et al., 2003) . Also, p53 has been shown to suppress HR induced at replication forks (Bertrand et al., 1997; Mekeel et al., 1997; Xia et al., 1997; Saintigny et al., 1999; Willers et al., 2000; Saintigny and Lopez, 2002) . Thus, it is possible that p53 maintains stability of the genome through its interaction with RAD51. Support for this notion also comes from the observation that p53-deficient cells exhibit increased levels of HR and elevated levels of the RAD51 protein (Bertrand et al., 1997; Mekeel et al., 1997; Xia et al., 1997; Saintigny et al., 1999; Willers et al., 2000; Saintigny and Lopez, 2002) . In addition, the lethality of RAD51 and RAD51L1 knockout mice can be suppressed by additional knockout of p53 (Lim and Hasty, 1996; Shu et al., 1999) .
Although there is a clear association between p53, HR and RAD51, it is still unclear if p53 reduces the number of lesions recognized by HR, or if p53 suppresses HR as such, possibly by interaction with RAD51. Here, we show that the number of cells containing RAD51 foci is increased in p53À/À mouse embryonic fibroblasts (MEFs) and that these cells exhibit an increased level of DSBs at replication forks blocked by hydroxyurea (HU). These results suggest that p53 suppresses the amount of lesions recognized by HR rather than HR per sec.
Results

Elevated levels of RAD51 and RAD51 foci in p53À/À MEFs
It has previously been shown that wild-type p53 protein downregulates levels of the RAD51 protein in primary cells (Xia et al., 1997) . In line with these results, we found an increased level of the RAD51 protein in p53À/À primary MEFs as compared with p53 þ / þ MEFs isolated from a littermate (Figure 1a) .
The RAD51 protein is sometimes found in foci in the S phase of the cell cycle and cells overexpressing RAD51 may form RAD51 foci of higher order structures, which is dependent on p21 (Raderschall et al., 2002) . Since the RAD51 protein is present at higher levels in p53À/À cells, we investigated if these structures are formed. We found distinct RAD51 foci in both p53 þ / þ and p53À/À primary MEFs and no higher order structures (Figure 1b, c) . DNA was stained unevenly, which is a common feature when staining DNA in MEFs .
To determine if HR sites correlate with the level of RAD51 in both RAD51 overexpressing cells and p53À/À cells we investigated the RAD51 foci formation in p53À/À MEFs. We found that the number of cells containing RAD51 foci was higher in p53À/À than in p53 þ / þ MEFs (statistically significant in t-test Po0.05; Figure 2a ). These results are expected given the increased level of the RAD51 protein and that more p53À/À cells are found in the S phase of the cell cycle (Figure 2a) .
Since RAD51 foci form in response to DNA damage or replication arrest (Haaf et al., 1995; Lundin et al., 2002) , we wanted to investigate if this response is altered by p53. Previously, it has been shown that loss of p53 enhances HR induced by replication elongation inhibitors Saintigny and Lopez, 2002) . We used two inhibitors of replication, HU and thymidine (TdR) that have distinct different mode of action. HU quenches the free radical in ribonucleotide reductase and depletes the pools of several dNTP, which results in a blocked replication fork (Bianchi et al., 1986) and the formation of DNA double-strand breaks (DSBs) (Lundin et al., 2002) . On the other hand, TdR depletes only the dCTP pool, which slows the progression of the replication forks (Bjursell and Reichard, 1973) without formation of detectable DSBs (Lundin et al., 2002) . We found that the numbers of HU-induced RAD51 foci were similar in p53 þ / þ and p53À/À MEFs ( Figure 2b) . A slight increase in TdR-induced RAD51 foci was only observed in p53À/À MEFs (statistically significant in t-test Po0.05; Figure 2b ).
We also determined the amount of cells present in the S phase of the cell cycle following treatments. We found that the number of S-phase cells correlated with the amount of RAD51 foci in untreated MEFs. However, the correlation was not obvious in HU-or TdR-treated MEFs.
p53 influences the amount of DNA lesions formed during DNA replication p53 accumulates in cells following HU or aphidicolin treatment (Gottifredi et al., 2001) . Both these compounds block DNA replication and cause DSBs at stalled replication forks (Lundin et al., 2002; Helleday, unpublished) . To test if p53 is activated by the slowing of replication (following TdR treatment), we analysed the level of p53 after a 24 h treatment with HU or TdR. We also used the topoisomerase I inhibitor camptothecin (CPT) and topoisomerase II inhibitor etoposide (VP16) as positive controls. We found that p53 accumulates following all treatments (Figure 3a) . Interestingly, we found that p53 accumulates acutely following the 24-h TdR treatment, although this dose is considerably less toxic than the dose used with the other drugs (Table 1 ).
We also investigated the level of RAD51 protein following the various treatments ( Figure 3b ). We found that the level of RAD51 varied in treated p53 þ / þ cells. The level was either higher due to upregulation in response to damage or lower, which might be related to apoptotic cleavage of the protein (Flygare et al., 1998) . However, no consistency was found following the treatments in repeated experiments. In p53À/À cells, the levels of RAD51 did not change following treatments in repeated experiments but remained higher than in p53 þ / þ cells. It has previously been reported that p53 accumulated following replication arrest with HU or aphidicolin is transcriptionally dead (Gottifredi et al., 2001) . The reason for p53 accumulation in the intra-S checkpoint is not fully understood. In yeast, a rad53 checkpoint mutant cell line showed fork reversal and ssDNA accumulation at stalled replication forks (Sogo et al., 2002) . Rad53 is the yeast homologue of the human chk2, which is known to signal to p53 (Chehab et al., 2000; Hirao et al., 2000; Shieh et al., 2000) . Thus, it is possible that p53 protects stalled replication forks from forming substrates for HR. To test this hypothesis we investigated formation of DSBs using pulsed field gel electrophoresis in p53À/À and p53 þ / þ MEFs following treatment with HU, TdR, VP16 or CPT. We have previously shown that HU and VP16 induce DSBs close to newly replicated DNA in mammalian cells (Lundin et al., 2002 (Lundin et al., , 2003 . Here, we found an increased level of DSBs in p53À/À MEFs following treatment with HU or VP16 (Figure 4 ). In contrast, we found no DSBs in p53 þ / þ MEFs following HU treatment and a reduced number of DSBs following VP16 treatment. No DSBs were found following TdR treatments in either p53 þ / þ or p53À/À MEFs, in agreement with the fact that TdR does not cause detectable DSBs (Lundin et al., 2002) .
Repair of DSBs and replication restart in p53À/À cells
We show that treatment with HU is coupled with a high level of DSBs detectable by pulsed-field gel electrophoresis in p53À/À cells (Figure 4) . It is possible that these breaks persist and impair the ability of the replication fork to restart. To address this issue, we measured the incorporation of bromodeoxyuridine (BrdU) for 2 h following a 24-h HU treatment (2 mM) in p53 þ / þ and p53À/À cells. Our data show that BrdU is incorporated in p53 þ / þ and p53À/À MEFs following HU treatments (Figure 5a ). This is evidence that replication can be restarted in HU-treated MEFs regardless of p53 status. However, it appears that p53 þ / þ cells were better synchronized by this high dose of HU (2 mM), which might be explained by the lower level of p53 þ / þ cells normally found in the S phase of the cell cycle.
The incorporation of BrdU in p53À/À cells is not evidence for repair of the damaged replication fork. It may also reflect restart of replication at other sites. To see if the DSBs are repaired we left p53À/À MEFs time to repair the VP16-or HU-induced DSBs before analysing on pulse-field gel electrophoresis. We found that by 24 h after HU treatment, most of the DSBs are repaired (Figure 5b, c) . The repair of the HU and VP16 DSBs appeared to be slow. To determine if this reflects slow repair of HU damage or if this reflects a general slow repair in the p53À/À MEFs used here, we also investigated the repair kinetics of g-ray-induced DSBs as a reference. We found that repair of g-ray-induced DSBs showed similar kinetics as HU or VP16 (Figure 5d ), (Huang et al., 1999) . It has also been shown that cells overexpressing RAD51 are resistant to agents such as HU or VP16 (Lundin et al., 2003) . Since p53 is mutated in a wide variety of tumours, we wanted to test the hypothesis that p53À/À MEFs are also resistant to these agents. We found that p53À/À and p53 þ / þ MEFs were equally sensitive to either HU or VP16 ( Figure 6 ).
Discussion
Here, we found that p53À/À MEFs have more cells with RAD51 foci (Figure 2a ), in agreement with a general increase in HR previously reported in p53 mutated cells (Bertrand et al., 1997; Mekeel et al., 1997; Xia et al., 1997; Saintigny et al., 1999; Willers et al., 2000; Saintigny and Lopez, 2002) . However, we found that the numbers of HU-induced RAD51 foci were similar in p53 þ / þ and p53À/À MEFs. Although the sites for HR (RAD51 foci) are increased following HU treatments, these do not inform on the HR activity at each foci. Thus, although the overall induced RAD51 foci were similar in p53 þ / þ and p53À/À cells, our results are compatible with previous results that loss of p53 enhances HR induced by replication elongation inhibitors Saintigny and Lopez, 2002) . Here, we report that the level of RAD51 protein is increased in p53 null primary fibroblasts, which confirms earlier findings that p53-deficient cells have an increased level of RAD51 (Xia et al., 1997) . In addition, cells overexpressing RAD51 and p53À/À cells both show an elevated level of HR. Thus, the increased levels of HR in p53-deficient cells might be a consequence of elevated levels of the RAD51 protein (Xia et al., 1997) . Alternatively, p53 might suppress HR more directly by binding to HR intermediates (Lee et al., 1997; Subramanian and Griffith, 2002; Yang et al., 2002) . Another possibility is that p53 may protect DNA damage from occurring, which then would result in less HR repair and no induction of RAD51.
Here, we report an increased level of DSBs in p53À/À MEFs following treatment with HU or VP16 as compared with p53 þ / þ MEFs (Figure 4) . We used higher concentrations of the compounds in pulse-field gel electrophoresis, since it is less sensitive method than RAD51 foci formation. However, these results clearly show that the increased level of HR in p53À/À cells is correlated with more damage. Possibly, the increase in RAD51 protein and RAD51 foci in p53À/À cells might reflect an elevated HR repair response to more replication damage.
Our results also suggest that p53 might protect stalled replication forks, which could be related to its binding to and regulation of Holliday Junctions (Sturzbecher et al., 1996; Buchhop et al., 1997; Lee et al., 1997; Susse et al., 2000; Subramanian and Griffith, 2002) that may form at stalled replication forks (Zou and Rothstein, 1997; Sogo et al., 2002) .
By protecting stalled replication forks from processing into HR substrates p53 would allow alternative pathways to occur, such as reverse branch migration at chicken foot structures, possibly catalysed by BLM (Karow et al., 2000) . This would restore a replication fork by nonrecombinogenic means, explaining the lower HR levels in p53 þ / þ cells. Our hypothesis is supported by the fact that loss of both p53 and BLM synergistically enhance spontaneous HR (Sengupta et al., 2003) and that p53 regulates processing of Holliday Junctions catalysed by the BLM and WRN proteins (Yang et al., 2002) .
The reason why not all DSBs were abolished following VP16 treatment in p53 þ / þ cells might be related to the fact that VP16 also induces DSBs unrelated to DNA replication (Lundin et al., 2003) . We found no apparent difference between CPT-induced DSBs in p53 þ / þ and p53À/À MEFs, possibly because these DSBs are produced by a replication 'run off' mechanism and are independent of recombination (Strumberg et al., 2000; Arnaudeau et al., 2001) .
It is possible that HU-induced DSBs could cause a permanent arrest in p53À/À cells or that these DSBcontaining forks are not repaired. However, we found that replication is resumed in HU-treated p53À/À MEFs and that the DSBs were repaired ( Figure 5 ). These results are not surprising since HU is commonly used to synchronize cells in the S phase of the cell cycle regardless of the p53 status. We believe that the high HR frequencies found in HU-treated p53-deficient cells reflect the HR repair and restart of collapsed replication forks.
We found that p53À/À and p53 þ / þ MEFs were equally sensitive to either HU or VP16 (Figure 6 ), although RAD51 overexpressing cells are resistant to the same agents (Lundin et al., 2003) . This is likely to reflect an increase in DNA damage in p53À/À cells, which would give a different response than overexpressing RAD51. An alternatively explanation is that elevated RAD51 levels following either overexpression of RAD51 or knockout of p53 are functionally different. This may indicate that p53 regulates RAD51 at the protein level possibly by activating ubiquitin-conjugating enzymes that interact with RAD51 (i.e., UBC9/UBE2I, UBL-1, SUMO-1; Kovalenko et al., 1996; Shen et al., 1996a, b) or interfere with the phosphorylation of RAD51 by c-abl (Yuan et al., 1998; Chen et al., 1999) .
In conclusion, we show elevated levels of spontaneous RAD51 foci in p53À/À MEFs. Furthermore, we found fewer or no DSBs induced at stalled replication forks in p53 þ / þ MEFs; suggesting a protective role for p53 at stalled replication forks. These results appear not to be a consequence of a deregulated level of the RAD51 protein. Instead, we suggest that these results reflect a direct role of p53 in protecting stalled replication forks.
Materials and methods
Cell lines
The p53À/À or p53 þ / þ primary MEFs were isolated and genotyped as described elsewhere (Cranston et al., 1997; Zhang et al., 1999) and kept at a passage number lower than six. Cells were grown in Alpha medium (aMEM) with 15% foetal bovine serum and penicillin (100 U/ml) and streptomycin sulphate (100 mg/ml) at 371C under an atmosphere containing 5% CO 2 .
Immunoblotting and immunofluorescence
Western blot was carried out as described elsewhere (Lundin et al., 2003) . The antibodies used were OP03 (Oncogene) for p53, H92 (Santa Cruz) for RAD51 and A5060 (Sigma) for b-actin.
To visualize RAD51 foci, MEFs were plated onto coverslips and if applicable treated with 5 mM TdR or 0.2 mM HU for 24 h. Following treatment, coverslips were rinsed and stained with RAD51 antibody (H92 Santa Cruz) and visualized with Cy-3-conjugated goat anti-rabbit IgG antibody (Zymed) as described elsewhere (Lundin et al., 2003) . DNA was stained with 1 mg/ml To Pro (Molecular Probes). The means and standard deviation were calculated from four to six independent experiments. At least 300 nuclei were counted on each slide.
Pulsed-field gel electrophoresis
Cells (2-3 Â 10 6 ) were inoculated in flasks and grown over night prior to treatments. After 24 h of treatment, the cells were released from the flask by trypsinization and 1 Â 10 6 cells melted into each agarose insert (75 ml, 1% InCert Agarose, BMA). For g-ray treatments, cells were melted into each agarose insert prior to treatments. In the repair assay, the inserts were incubated in aMEM at 371C under an atmosphere containing 5% CO 2 . Following treatments and repair, inserts were incubated in 0.5 M EDTA, 1% N-laurylsarcosyl and proteinase K (1 mg/ml) at 501C for 48 h and thereafter, washed four times in TE-buffer prior to loading onto an agarose separation gel (1% Chromosomal grade agarose, Bio-Rad). Separation was performed on a CHEF DR III equipment (BioRad; 1201 field angle, 240 s switch time, 4 V/cm) for 18 h. The gel was stained with ethidium bromide (5 mg/ml) overnight and subsequently analysed using Image Gauge software (FLA-3000, Fujifilm).
Flow cytometry
Cells (1 Â 10 6 ) were inoculated onto a Petri dish over night and then exposed to HU or TdR for 24 h. Following the treatment, the cells were rinsed in PBS and aMEM added. A subsequent 1 h treatment with 10 mM BrdU was initiated after 2 h and the flasks were then trypsinized and the released cells washed in 10 ml PBS before fixation and analysis using an FACS Calibur, as previously described (Arnaudeau et al., 2001 ).
Toxicity assay
In the toxicity assay, 2500 cells were plated onto a Petri dish (Ø 100 mm) 24 h prior to a continuous HU or VP16 treatment. VP16 was dissolved in dimethylsulphoxide (DMSO) at a final concentration of 0.2%. After 7-12 days, when colonies were observed, the plates were harvested and the colonies were fixed and stained using methylene blue in methanol (4 g/l). Colonies containing more than 50 cells were counted.
Abbreviations CPT, camptothecin; DSBs, DNA double-strand breaks; HR, homologous recombination; HU, hydroxyurea; MEFs, mouse embryonic fibroblasts; TdR, thymidine; VP16, etoposide.
